Alcatel-Lucent Enterprise Hosts First Global Virtual Conference for Partners
1.2.2021 12:00:00 EET | Business Wire | Press release
Alcatel-Lucent Enterprise , a leading digital-age networking, communications and cloud solutions provider, is hosting its Connex21 global partner conference virtually between February 1-4, 2021. It is the latest in an extensive program of virtual events, after the company adapted its priorities to keep employees safe and maintain business continuity for partners and customers.
Over 2,100 Alcatel-Lucent Enterprise partners and industry analysts from all over the world have registered to attend the summit. Under the theme ‘Build 2 Last’, Connex21 will feature speakers including CEO Jack Chen and Rukmini Glanard, Executive Vice President Global Sales, Services and Marketing.
Jack and Rukmini will join other Alcatel-Lucent Enterprise business leaders to outline the company’s 2021 strategy, discuss core business objectives, explain the product roadmap, and explore the growth opportunities this year poses for the business and its international partners.
“Last year was very difficult for every one of us,” comments Jack Chen, CEO of Alcatel-Lucent Enterprise. “The current situation has changed the way we work, and some of these changes will become permanent. This crisis has highlighted the critical need for digital transformation. Digital technology is enabling businesses to generate revenue, retain staff, and survive in challenging conditions. Technology is helping us all to adapt and find ways to grow.”
Over the course of Connex21, executives at the company will host dedicated sessions to demonstrate the impact its innovations are having in vertical industries across the globe. Product specialists will present the Alcatel-Lucent Enterprise roadmap for new solutions designed to support partners in solving business issues and driving growth for customers. The business will also outline its plan to support its partner community in 2021 with Cloud, Network and Communications solutions designed for critical verticals such as Transportation, Healthcare, Education, Government and Hospitality.
“Alcatel-Lucent Enterprise has a long history of evolving with the times,” says Jack Chen. “We’ve had to adapt to address the needs of the enterprise successfully for over 100 years. Versatility is in our DNA and originates from our ability to embrace innovation. Our solutions help businesses grow, irrespective of the market conditions. Our partners believe in our vision to help organisations grow through innovation and, together, we work tirelessly to achieve it. We want to continue to build great relationships and solutions that will last long into the future.”
Alcatel-Lucent Enterprise has a strong ecosystem of 2,900 direct business partners all over the world. This helps the company achieve an effective international reach, with a local focus, for over 830,000 customers in 100 countries around the world.
About Alcatel-Lucent Enterprise
Alcatel-Lucent Enterprise delivers the customised technology experiences enterprises need to make everything connect.
ALE provides digital-age networking, communications and cloud solutions tailored to ensure customers’ success, with flexible business models in the cloud, on premises, and hybrid. All solutions have built-in security and limited environmental impact.
Over 100 years of innovation have made Alcatel-Lucent Enterprise a trusted advisor to more than 830,000 customers in 100 countries around the world.
The privately-owned company with headquarters in France has over 2,900 direct business partners worldwide, achieving an effective global reach with a local focus.
For more information: www.al-enterprise.com .
LinkedIn , Facebook , Twitter , Instagram .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210201005157/en/
Contact information
UK Press
Lisa McGauley
lisa@fox.agency
Global Press
Carine Bowen
press@al-enterprise.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom